FDA Clearance Tracker · P140004-S010
Superion® Indirect Decompression System
Last checked: Nov 20, 2026Latest source record: Nov 16, 2018 (this decision)Source: openFDAMethods & limitations
Decided
Nov 16, 2018
Approved
Time to decision
365 days
Received Nov 16, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P140004-S010
- Device name
- Superion® Indirect Decompression System
- Applicant
- Boston Scientific Neuromodulation
- Applicant location
- Valencia, CA
- Received
- Nov 16, 2017
- Decided
- Nov 16, 2018
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P140004
Device type
- Device class
- Class III
- Specialty
- Orthopedic SurgerySpine
FDA's approval statement
As written in FDA's record.
Approval for revised labeling which incorporates data from the completed Post-Approval Study.
Source documents
Other decisions for Boston Scientific Neuromodulation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251247 · Decided Aug 7, 2025 · 106 days after receipt
Device type: Generator, Lesion, Radiofrequency (GXD) · Neurology & Neurosurgery
K233801 · Decided Aug 23, 2024 · 268 days after receipt
Device type: Stimulator, Spinal-Cord, Implanted (Pain Relief) (GZB) · Neurology & Neurosurgery
K232415 · Decided Aug 21, 2024 · 376 days after receipt
Device type: Stimulator, Peripheral Nerve, Implanted (Pain Relief) (GZF) · Neurology & Neurosurgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.